Trial Details

TERMINATED
Basic Information
Clinical ID c2346
Identifier NCT03635112
Trial Title Efficacy and Safety of TD-1473 in Crohn's Disease
Trial URL Visit Original Page
Study Information
Study Results

YES
Conditions Crohn's Disease
Interventions DRUG: Placebo|DRUG: TD-1473
Participant Information
Sponsor Theravance Biopharma
City Birmingham
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2018-11-19
Primary Completion Date 2021-12-30
Completion Date 2021-12-30